Evidence map›Paper›PMID 33668726›Full record

Observational studyNutrients2021

Identifying Clusters of Adherence to Cardiovascular Risk Reduction Behaviors and Persistence with Medication in New Lipid-Lowering Drug Users. Impact on Healthcare Utilization.

Sara Malo, María José Rabanaque, Lina Maldonado, Belén Moreno-Franco, Armando Chaure-Pardos, María Jesús Lallana, María Pilar Rodrigo, Isabel Aguilar-Palacio

Abstract readObservational Study
In one paragraph

Observational study in Nutrients, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sara MaloDepartment of Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0002-7194-8275
María José RabanaqueDepartment of Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0002-6671-5661
Lina MaldonadoFundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 50009 Zaragoza, Spain.ORCID 0000-0003-1647-3462
Belén Moreno-FrancoDepartment of Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.
Armando Chaure-PardosDepartment of Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.
María Jesús LallanaFundación Instituto de Investigación Sanitaria de Aragón (IIS Aragón), 50009 Zaragoza, Spain.ORCID 0000-0002-3803-5298
María Pilar RodrigoGrupo de Investigación en Servicios Sanitarios de Aragón (GRISSA), Spain.
Isabel Aguilar-PalacioDepartment of Preventive Medicine and Public Health, University of Zaragoza, 50009 Zaragoza, Spain.ORCID 0000-0001-7293-701X

Funding

Proyecto del Fondo de Investigación Sanitaria, the Instituto de Salud Carlos III, and the European Fund for Regional De-velopment (FEDER) PI17/01704
6 · The paper itself

Abstract

We sought to identify specific profiles of new lipid-lowering drug users based on adherence to a healthy lifestyle and persistence with medication, and to characterize co-morbidities, co-treatments, and healthcare utilization for each of the profiles identified. Observational study in 517 participants in the Aragon Workers' Health Study (AWHS) without previous cardiovascular disease (CVD) and who initiated lipid-lowering therapy. Data were collected from workplace medical examinations and administrative health databases (2010-2018). Using cluster analysis, we identified distinct patient profiles based on persistence with therapy and lifestyle. We then compared characteristics, morbidity, and healthcare utilization across clusters. Participants were aggregated into four clusters based on persistence with therapy, smoking status, adherence to Mediterranean diet, and physical activity. In cluster 1 (

Indexed as

Healthy LifestyleCardiovascular DiseasesExerciseHeart Disease Risk FactorsHumansHypolipidemic AgentsMaleMedication AdherenceMiddle AgedRisk FactorsRisk Reduction BehaviorHypolipidemic Agentscardiovascular diseasehealthy lifestylemedication adherenceprimary preventionworkplace

Identifiers

PMID33668726
PMCPMC7996322

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.